Cargando…

HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death

Detalles Bibliográficos
Autores principales: Baehner, FL, Achacoso, NS, Maddala, T, Alexander, C, Shak, S, Quesenberry, CP, Goldstein, LC, Gown, AM, Habel, LA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284889/
http://dx.doi.org/10.1186/bcr2286
_version_ 1782351485672095744
author Baehner, FL
Achacoso, NS
Maddala, T
Alexander, C
Shak, S
Quesenberry, CP
Goldstein, LC
Gown, AM
Habel, LA
author_facet Baehner, FL
Achacoso, NS
Maddala, T
Alexander, C
Shak, S
Quesenberry, CP
Goldstein, LC
Gown, AM
Habel, LA
author_sort Baehner, FL
collection PubMed
description
format Online
Article
Text
id pubmed-4284889
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42848892015-01-15 HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death Baehner, FL Achacoso, NS Maddala, T Alexander, C Shak, S Quesenberry, CP Goldstein, LC Gown, AM Habel, LA Breast Cancer Res Poster Presentation BioMed Central 2009 2009-06-23 /pmc/articles/PMC4284889/ http://dx.doi.org/10.1186/bcr2286 Text en Copyright © 2009 BioMed Central Ltd.
spellingShingle Poster Presentation
Baehner, FL
Achacoso, NS
Maddala, T
Alexander, C
Shak, S
Quesenberry, CP
Goldstein, LC
Gown, AM
Habel, LA
HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death
title HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death
title_full HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death
title_fullStr HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death
title_full_unstemmed HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death
title_short HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death
title_sort her2 assessment using fluorescence in situ hybridization compared with oncotype dx and association with risk of breast cancer death
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284889/
http://dx.doi.org/10.1186/bcr2286
work_keys_str_mv AT baehnerfl her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath
AT achacosons her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath
AT maddalat her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath
AT alexanderc her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath
AT shaks her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath
AT quesenberrycp her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath
AT goldsteinlc her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath
AT gownam her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath
AT habella her2assessmentusingfluorescenceinsituhybridizationcomparedwithoncotypedxandassociationwithriskofbreastcancerdeath